Peter A. Pinto, M.D.
- Center for Cancer Research
- National Cancer Institute
- Building 10, Hatfield CRC, Room 2W-5940
- Bethesda, MD 20892
- 240-858-7200
- pintop@mail.nih.gov
RESEARCH SUMMARY
Dr. Pinto is an Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md. Following a residency in Urologic Surgery at Long Island Jewish Medical Center - Albert Einstein College of Medicine in New York, he was a Fellow and Clinical Instructor at the Brady Urologic Institute, Johns Hopkins Hospital. Dr. Pinto is a Board Certified Urologic Surgeon specializing in oncology and is the Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. He is nationally and internationally recognized as an expert in the minimally invasive treatment of urologic cancers, specializing in laparoscopic and robotic surgery for prostate, kidney, bladder, and testicular cancer.
Areas of Expertise
Information for Patients
Learn more about our clinical trials and the highly specialized care teams that lead them.
Peter A. Pinto, M.D.
Clinical Trials
Research
Dr. Pinto’s scientific mission is development of novel diagnostic and treatment modalities for localized and locally advanced prostate cancer.
Research efforts are centered on investigation of multiparametric MRI (mpMRI) in prostate cancer to improve diagnosis with mpMRI whole-mount pathology correlation and creation of a tumor-directed biopsy device; development of image-guided focal prostate cancer therapy; and evaluation of immunotherapy, molecular targeted therapy or other pharmacotherapies in the management of localized or locally advanced prostate cancer.
Publications
MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis
Neoadjuvant PROSTVAC prior to radical prostatectomy enhances T-cell infiltration into the tumor immune microenvironment in men with prostate cancer
The role of multiparametric MRI in biopsy-naive prostate cancer
Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer
A Magnetic Resonance Imaging-Based Prediction Model for Prostate Biopsy Risk Stratification
Biography
Peter A. Pinto, M.D.
Dr. Pinto is an Investigator and faculty member in the Urologic Oncology Branch of the National Cancer Institute, National Institutes of Health in Bethesda, Md. Following a residency in Urologic Surgery at Long Island Jewish Medical Center - Albert Einstein College of Medicine in New York, he was a Fellow and Clinical Instructor at the Brady Urologic Institute, Johns Hopkins Hospital. Dr. Pinto is a Board Certified Urologic Surgeon specializing in oncology and is the Director of the Urologic Oncology Fellowship Program at the National Cancer Institute. He is nationally and internationally recognized as an expert in the minimally invasive treatment of urologic cancers, specializing in laparoscopic and robotic surgery for prostate, kidney, bladder, and testicular cancer.
Job Vacancies
| Position | Degree Required | Contact Name | Contact Email |
|---|---|---|---|
| Clinical Fellow - urology, oncology, fellowship, training | M.D. or equivalent | Peter Pinto | pintop@mail.nih.gov |
